SCHEDULE: SCYNEXIS Inc. Ownership Update

Federated Hermes, Inc. and associated entities report a 4.45% beneficial ownership stake in SCYNEXIS Inc. common stock as of June 30, 2026.

Summary

• This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership of SCYNEXIS Inc. common stock.
• Federated Hermes, Inc., along with the Voting Shares Irrevocable Trust, Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue, collectively hold 55,207 shares.
• This holding represents 4.45% of the class of securities.
• The filing clarifies that these entities are not admitting beneficial ownership of securities held by managed funds and expressly disclaim beneficial ownership of such securities.
• The reporting persons are classified as investment companies, investment advisers, and parent holding companies or control persons.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of ownership and does not contain operational or financial performance information.

Future Outlook

This filing is an update on ownership and does not contain forward-looking statements or guidance regarding SCYNEXIS Inc.'s future performance.

Management Comments

• In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors and significant shareholders, indicating changes in holdings. This filing reflects a specific ownership percentage by Federated Hermes and related entities in SCYNEXIS Inc., a biotechnology company.

Stakeholder Impact

• Shareholders: Provides transparency on significant ownership stakes, which can influence market perception and potential future corporate actions.

Key Dates

Keywords

SCYNEXIS Inc., Schedule 13G, Beneficial Ownership, Federated Hermes, Common Stock, SEC Filing, Ownership Stake